Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP964893.RAQpTlLh-CW87rNom0yGYX9tXVUen9-33pPBui31zrvp4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP964893.RAQpTlLh-CW87rNom0yGYX9tXVUen9-33pPBui31zrvp4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP964893.RAQpTlLh-CW87rNom0yGYX9tXVUen9-33pPBui31zrvp4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP964893.RAQpTlLh-CW87rNom0yGYX9tXVUen9-33pPBui31zrvp4130_provenance.
- NP964893.RAQpTlLh-CW87rNom0yGYX9tXVUen9-33pPBui31zrvp4130_assertion description "[The MAL gene, which has been shown to confer resistance to cancer therapy, was most highly overexpressed in short-term survivors (3-fold compared with long-term survivors, and 29-fold compared with early-stage cases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP964893.RAQpTlLh-CW87rNom0yGYX9tXVUen9-33pPBui31zrvp4130_provenance.
- NP964893.RAQpTlLh-CW87rNom0yGYX9tXVUen9-33pPBui31zrvp4130_assertion evidence source_evidence_literature NP964893.RAQpTlLh-CW87rNom0yGYX9tXVUen9-33pPBui31zrvp4130_provenance.
- NP964893.RAQpTlLh-CW87rNom0yGYX9tXVUen9-33pPBui31zrvp4130_assertion SIO_000772 15897565 NP964893.RAQpTlLh-CW87rNom0yGYX9tXVUen9-33pPBui31zrvp4130_provenance.
- NP964893.RAQpTlLh-CW87rNom0yGYX9tXVUen9-33pPBui31zrvp4130_assertion wasDerivedFrom befree-20150227 NP964893.RAQpTlLh-CW87rNom0yGYX9tXVUen9-33pPBui31zrvp4130_provenance.
- NP964893.RAQpTlLh-CW87rNom0yGYX9tXVUen9-33pPBui31zrvp4130_assertion wasGeneratedBy ECO_0000203 NP964893.RAQpTlLh-CW87rNom0yGYX9tXVUen9-33pPBui31zrvp4130_provenance.
- befree-20150227 importedOn "2015-02-27" NP964893.RAQpTlLh-CW87rNom0yGYX9tXVUen9-33pPBui31zrvp4130_provenance.